ES413279A1 - Un procedimiento para la preparacion de compuestos biologi-camente activos en el tratamiento de la hipoglicemia. - Google Patents

Un procedimiento para la preparacion de compuestos biologi-camente activos en el tratamiento de la hipoglicemia.

Info

Publication number
ES413279A1
ES413279A1 ES413279A ES413279A ES413279A1 ES 413279 A1 ES413279 A1 ES 413279A1 ES 413279 A ES413279 A ES 413279A ES 413279 A ES413279 A ES 413279A ES 413279 A1 ES413279 A1 ES 413279A1
Authority
ES
Spain
Prior art keywords
group
formula
alk
carboxylic acid
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES413279A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robapharm AG
Original Assignee
Robapharm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robapharm AG filed Critical Robapharm AG
Publication of ES413279A1 publication Critical patent/ES413279A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
ES413279A 1972-04-04 1973-04-03 Un procedimiento para la preparacion de compuestos biologi-camente activos en el tratamiento de la hipoglicemia. Expired ES413279A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1528072A GB1437781A (en) 1972-04-04 1972-04-04 Pyridine derivatives having hypoglycaemic activity

Publications (1)

Publication Number Publication Date
ES413279A1 true ES413279A1 (es) 1976-01-01

Family

ID=10056262

Family Applications (1)

Application Number Title Priority Date Filing Date
ES413279A Expired ES413279A1 (es) 1972-04-04 1973-04-03 Un procedimiento para la preparacion de compuestos biologi-camente activos en el tratamiento de la hipoglicemia.

Country Status (20)

Country Link
JP (1) JPS49100091A (xx)
AR (1) AR208269A1 (xx)
AT (1) AT339301B (xx)
BE (1) BE797715A (xx)
BG (1) BG20352A3 (xx)
CA (1) CA999868A (xx)
CH (1) CH576961A5 (xx)
CS (1) CS183689B2 (xx)
DD (1) DD106834A5 (xx)
DE (1) DE2316881A1 (xx)
ES (1) ES413279A1 (xx)
FR (1) FR2182933B1 (xx)
GB (1) GB1437781A (xx)
HU (1) HU165731B (xx)
IE (1) IE37412B1 (xx)
IL (1) IL41825A (xx)
NL (1) NL7304610A (xx)
PL (1) PL96043B1 (xx)
RO (2) RO63069A (xx)
ZA (1) ZA731853B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409227A (en) 1979-08-09 1983-10-11 The Dow Chemical Co. 4-(((Heterocyclo)thio)methyl)benzoic acids, esters and amides and their pharmaceutical use
DE69202126T2 (de) * 1991-07-03 1995-08-24 Unilever Nv Verbesserte Schokolade-Zusammensetzung.
DK0521549T3 (da) * 1991-07-03 1995-12-27 Unilever Plc Chokoladefyldninger indeholdende et additiv mod dannelse af gråt overtræk
US5453433A (en) * 1994-05-13 1995-09-26 Sterling Winthrop Inc. Thiadiazoles and antipicornaviral compositions
JP2000509373A (ja) * 1996-04-19 2000-07-25 ノボ ノルディスク アクティーゼルスカブ ホスホチロシン認識ユニットを有する分子のモジュレーター
US6043247A (en) * 1996-04-19 2000-03-28 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
ES2226413T3 (es) 1998-02-26 2005-03-16 Celltech Therapeutics Limited Derivados de fenilalanina como inhibidores de alfa-4 integrinas.
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9811969D0 (en) 1998-06-03 1998-07-29 Celltech Therapeutics Ltd Chemical compounds
GB9812088D0 (en) 1998-06-05 1998-08-05 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) * 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9821222D0 (en) 1998-09-30 1998-11-25 Celltech Therapeutics Ltd Chemical compounds
GB9825652D0 (en) 1998-11-23 1999-01-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6534513B1 (en) 1999-09-29 2003-03-18 Celltech R&D Limited Phenylalkanoic acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
WO2001079173A2 (en) 2000-04-17 2001-10-25 Celltech R & D Limited Enamine derivatives as cell adhesion molecules
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
WO2002004426A1 (en) 2000-07-07 2002-01-17 Celltech R & D Limited Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
EP1305291A1 (en) 2000-08-02 2003-05-02 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives
MXPA03011558A (es) * 2001-06-12 2004-03-26 Wellstat Therapeutics Corp Compuestos para el tratamiento de desordenes metabolicos.
GB0405033D0 (en) * 2004-03-05 2004-04-07 Karobio Ab Novel pharmaceutical compositions
TWI490214B (zh) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
WO2015000900A2 (en) * 2013-07-01 2015-01-08 Givaudan Sa Organic compounds
WO2016167153A1 (ja) * 2015-04-15 2016-10-20 長谷川香料株式会社 ピリジン誘導体またはその塩を有効成分とする香味変調剤
EP3440052B1 (en) * 2016-04-06 2023-10-25 University Of Oulu Compounds for use in the treatment of cancer

Also Published As

Publication number Publication date
GB1437781A (en) 1976-06-03
JPS49100091A (xx) 1974-09-20
IL41825A0 (en) 1973-05-31
CS183689B2 (en) 1978-07-31
FR2182933A1 (xx) 1973-12-14
IL41825A (en) 1977-03-31
IE37412L (en) 1973-10-04
AT339301B (de) 1977-10-10
PL96043B1 (pl) 1977-11-30
ZA731853B (en) 1974-01-30
AR208269A1 (es) 1976-12-20
CH576961A5 (xx) 1976-06-30
ATA286773A (de) 1977-02-15
RO62274A (fr) 1977-12-15
BE797715A (fr) 1973-10-03
BG20352A3 (xx) 1975-11-05
DD106834A5 (xx) 1974-07-05
CA999868A (en) 1976-11-16
NL7304610A (xx) 1973-10-08
FR2182933B1 (xx) 1976-05-14
IE37412B1 (en) 1977-07-20
HU165731B (xx) 1974-10-28
RO63069A (fr) 1978-08-15
DE2316881A1 (de) 1973-10-11

Similar Documents

Publication Publication Date Title
ES413279A1 (es) Un procedimiento para la preparacion de compuestos biologi-camente activos en el tratamiento de la hipoglicemia.
KR880001591A (ko) 테트라하이드로 나프탈렌 및 인단유도체
FR2414039A1 (fr) Derives de prostacycline, leur procede de preparation et leurs applications en therapeutique
YU69991A (sh) Derivati piridina
JPS5412372A (en) Thiazolidine derivative and its preparation
GB1384504A (en) Bridgeheadheterocyclic compounds their production and their medicinal use
ES405983A1 (es) Procedimiento para la preparacion de derivados de fenileti-lamina fluoralcohilados.
FR2354761A1 (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
GB1438265A (xx)
NO811798L (no) Nye substituerte 3-fenoksy-1-alkoksykarbonyl-alkylaminopropanoler-2 med beta-reseptorblokkerende egenskaper
IE40068B1 (en) Isoquinoline derivatives and process for preparing them and phamaceutical preparations comprising them
FR2372836A1 (fr) Derives de l'acide propionique, leurs procedes de preparation et leur application en therapeutique
SE7701187L (sv) Nya piperazinderivat och sett att framstella desamma
ES476266A1 (es) Procedimiento para la preparacion de diaminas ciclicas n,n'-disustituidas.
JPS5283380A (en) Synthesis of thiocarbostyril derivatives
GB1391862A (en) Benzodiazepines
FR2390954A1 (fr) Nouvelles guanylhydrazones, leurs procedes de preparation et medicaments les contenant
JPS5419969A (en) Proline derivative and its preparation
FR2368489A1 (fr) Derives de la clavuline, leur procede de preparation et leur application en therapeutique
JPS5677272A (en) Monoester compound of kojic acid
FI892685A0 (fi) Menetelmä uusien, sytostaattisesti vaikuttavien antrasykliinijohdannaisten valmistamiseksi
ES433131A1 (es) Procedimiento para la obtencion de derivados de 1-fenoxi-3- amino-propan-2-ol.
ES369304A1 (es) Procedimiento de preparacion de nuevos derivados nitrogena-dos de la metil-2 benzil-3 imidazo-3h (4,5-b) piridina.
GB1444879A (en) 3-acylamino-6-amino-3,4-dihydro-2-pyridones and their use as medicaments
ES420221A1 (es) Un procedimiento para la preparacion de compuestos deriva- dos de estibazol.